CH635328A5 - Derivatives of N-(5-tetrazolyl)benzamide and pharmaceutical composition containing them - Google Patents

Derivatives of N-(5-tetrazolyl)benzamide and pharmaceutical composition containing them Download PDF

Info

Publication number
CH635328A5
CH635328A5 CH1114178A CH1114178A CH635328A5 CH 635328 A5 CH635328 A5 CH 635328A5 CH 1114178 A CH1114178 A CH 1114178A CH 1114178 A CH1114178 A CH 1114178A CH 635328 A5 CH635328 A5 CH 635328A5
Authority
CH
Switzerland
Prior art keywords
group
benzamide
hydroxy
ethyl
carbon atoms
Prior art date
Application number
CH1114178A
Other languages
English (en)
French (fr)
Inventor
Roger Edward Ford
Philip Knowles
Edward Lunt
Stuart Malcolm Marshall
Anthony John Henty Summers
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of CH635328A5 publication Critical patent/CH635328A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/30—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH1114178A 1977-10-28 1978-10-27 Derivatives of N-(5-tetrazolyl)benzamide and pharmaceutical composition containing them CH635328A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB45083/77A GB1588242A (en) 1977-10-28 1977-10-28 N-(tetrazol-5-yl)-salicylamide derivatives

Publications (1)

Publication Number Publication Date
CH635328A5 true CH635328A5 (en) 1983-03-31

Family

ID=10435819

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1114178A CH635328A5 (en) 1977-10-28 1978-10-27 Derivatives of N-(5-tetrazolyl)benzamide and pharmaceutical composition containing them

Country Status (5)

Country Link
JP (1) JPS5470275A (de)
CH (1) CH635328A5 (de)
DE (1) DE2846891A1 (de)
FR (1) FR2407208A1 (de)
GB (1) GB1588242A (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526979A (en) * 1983-07-22 1985-07-02 Merrell Dow Pharmaceuticals Inc. Carbamates and oxalamides of amino-N-(1H-tetrazol-5-yl)benzamides
US5073566A (en) * 1989-11-30 1991-12-17 Eli Lilly And Company Angiotensin ii antagonist 1,3-imidazoles and use thereas
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
TW200600086A (en) 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
BRPI0516595A (pt) 2004-10-16 2008-09-23 Astrazeneca Ab processo para fabricar um composto, e, composto
TW200714597A (en) 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
BRPI0622262A2 (pt) 2005-07-09 2011-08-09 Astrazeneca Ab composto, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, processo para a preparação de um composto
TW200738621A (en) 2005-11-28 2007-10-16 Astrazeneca Ab Chemical process
TW200825063A (en) 2006-10-23 2008-06-16 Astrazeneca Ab Chemical compounds
SA07280576B1 (ar) 2006-10-26 2011-06-22 استرازينيكا ايه بي مركبات بنزويل أمينو سيكليل غير متجانسة بأعتبارها عوامل منشطة للجلوكوكيناز
KR20090090390A (ko) 2006-12-21 2009-08-25 아스트라제네카 아베 Ｇｌｋ 활성제로서 유용한 신규 결정 화합물
EA201100097A1 (ru) 2008-08-04 2011-10-31 Астразенека Аб Производные пиразоло[3,4]пиримидин-4-ила и их применения для лечения диабета и ожирения
GB0902406D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
GB0902434D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
AR076221A1 (es) * 2009-04-09 2011-05-26 Astrazeneca Ab Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad
WO2010116177A1 (en) 2009-04-09 2010-10-14 Astrazeneca Ab A pyrazolo [4,5-e] pyrimidine derivative and its use to treat diabetes and obesity
JP5982004B2 (ja) * 2011-11-03 2016-08-31 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 除草活性を有するオキシム−エーテル−置換ベンゾイルアミド類
US10785979B2 (en) * 2015-08-25 2020-09-29 Bayer Cropscience Aktiengesellschaft Substituted ketoxime benzoylamides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2750393A (en) * 1954-12-01 1956-06-12 Sterling Drug Inc Iodinated 5-henzamidotetrazoles and preparation thereof

Also Published As

Publication number Publication date
DE2846891A1 (de) 1979-05-10
FR2407208A1 (fr) 1979-05-25
GB1588242A (en) 1981-04-23
JPS5470275A (en) 1979-06-05
FR2407208B1 (de) 1981-12-18

Similar Documents

Publication Publication Date Title
CH635328A5 (en) Derivatives of N-(5-tetrazolyl)benzamide and pharmaceutical composition containing them
FR2658511A1 (fr) Nouveaux derives de benzimidazole et d'azabenzimidazole, antagonistes des recepteurs au thromboxane; leurs procedes de preparation, compositions pharmaceutiques les contenant.
CH639653A5 (fr) Aminothiazoles et composition pharmaceutique les contenant.
CH643546A5 (fr) Procede pour la preparation de derives d'hydantoine.
FR2500751A1 (fr) Compositions pharmaceutiques anti-inflammatoires topiques a base de sels d'acides carboxyliques, nouveaux sels d'acides carboxyliques et leur preparation
FR2542740A1 (fr) Derives de thiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2663633A1 (fr) Nouvelles chalcones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
CA1111027A (fr) Aza-8 purinones-6
CH635832A5 (fr) Derives du tetrazole et composition pharmaceutique les contenant.
EP0239436B1 (de) Tricyclisches Derivat, nämlich 5-(3-Chloro-6-methyl-5,5-dioxo-6,11-dihydro-dibenzo[c,f] [1,2]-thiazepin-11-yl amino)-pentansäure, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
EP0482183A1 (de) Histamin-h3-rezeptor-agonisten zur therapeutischen anwendung und pharmazeutischen zusammensetzungen mit histamin-h3-rezeptor-agonistischen wirkung.
FR2460287A1 (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
EP0174242A2 (de) 1-(Aminophenyl)-2-amino-propanon-Derivate, deren Verwendung in Therapie und Verfahren zu deren Herstellung
LU84860A1 (fr) Nouveau derive de la pyrazolo(1,5-a)pyridine,sa preparation et les compositions pharmaceutiques qui le contiennent
BE646581A (de)
CH658786A5 (fr) Medicaments qui contiennent d'alpha-(n-pyrrolyl)-acides ou de leurs sels ou esters.
BE1003518A3 (fr) Nouveaux derives de la methoxycarbonyl-2-n,n'-di-(trimethoxybenzoyle) piperazine, un procede pour leur preparation et compositions therapeutiques en contenant.
CH620678A5 (en) Process for the preparation of a derivative of piperidine
CA2491989C (fr) Composes a activite anti-parasitaire et medicaments les renfermant
FR4456M (fr) Compositions pharmaceutiques utilisées comme anti-convulsants.
WO1996001830A1 (fr) Derives de silylmethyl-anilines, leurs procedes de fabrication et leur utilisation comme medicament
CA1068270A (fr) Diamino-2,4-bromo-5 chloro-6 pyrimidines utilisables comme medicaments et procede pour leur preparation
BE882414A (fr) Nouveaux acides et esters 4-amino-3-quinoleine-carboxyliques, utiles notamment comme agents antisecretoires et anti-ulcere
FR2572730A1 (fr) Nouveaux derives de l'arsenic, leur preparation et leur application, notamment comme medicaments antiparasitaires
CH629796A5 (en) Therapeutically active compounds of 4-(2-thienylmethylamino)benzoic acid

Legal Events

Date Code Title Description
PL Patent ceased